Douglas Scott Micalizzi, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neoplastic Cells, Circulating | 6 | 2022 | 933 | 1.860 |
Why?
|
Epithelial-Mesenchymal Transition | 6 | 2022 | 713 | 1.320 |
Why?
|
Neoplasm Metastasis | 8 | 2022 | 4839 | 1.230 |
Why?
|
Blood Chemical Analysis | 1 | 2024 | 440 | 0.820 |
Why?
|
Ribosomal Proteins | 2 | 2020 | 360 | 0.720 |
Why?
|
Transforming Growth Factor beta | 6 | 2021 | 2006 | 0.700 |
Why?
|
Homeodomain Proteins | 8 | 2015 | 2417 | 0.690 |
Why?
|
Breast Neoplasms | 13 | 2023 | 20774 | 0.620 |
Why?
|
Protein Biosynthesis | 1 | 2021 | 2126 | 0.450 |
Why?
|
Neoplastic Stem Cells | 3 | 2017 | 1376 | 0.450 |
Why?
|
Neoplasm Invasiveness | 2 | 2018 | 3612 | 0.400 |
Why?
|
Receptors, Transforming Growth Factor beta | 2 | 2012 | 314 | 0.360 |
Why?
|
Early Detection of Cancer | 1 | 2024 | 3070 | 0.350 |
Why?
|
Mesoderm | 2 | 2009 | 686 | 0.350 |
Why?
|
Mammary Glands, Human | 2 | 2010 | 200 | 0.350 |
Why?
|
Cell Transdifferentiation | 1 | 2010 | 171 | 0.340 |
Why?
|
Mass Screening | 1 | 2024 | 5238 | 0.310 |
Why?
|
Epithelium | 2 | 2009 | 1680 | 0.310 |
Why?
|
Cell Line, Tumor | 12 | 2022 | 16665 | 0.300 |
Why?
|
Mice, SCID | 4 | 2022 | 2715 | 0.290 |
Why?
|
Mice, Nude | 4 | 2022 | 3689 | 0.260 |
Why?
|
Embryonic Development | 1 | 2010 | 704 | 0.260 |
Why?
|
Pancreatic Neoplasms | 1 | 2022 | 5249 | 0.250 |
Why?
|
Mammary Neoplasms, Experimental | 3 | 2012 | 520 | 0.230 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2012 | 2940 | 0.220 |
Why?
|
Neoplastic Processes | 1 | 2022 | 35 | 0.220 |
Why?
|
Neoplasm Transplantation | 3 | 2020 | 2085 | 0.220 |
Why?
|
Neoplasms | 4 | 2024 | 21596 | 0.210 |
Why?
|
Tristetraprolin | 1 | 2020 | 42 | 0.180 |
Why?
|
Gene Expression Regulation, Neoplastic | 8 | 2020 | 8425 | 0.170 |
Why?
|
Mesenchymal Stem Cells | 1 | 2010 | 1625 | 0.170 |
Why?
|
Epithelial Cells | 2 | 2010 | 3678 | 0.160 |
Why?
|
Tumor Escape | 1 | 2021 | 349 | 0.160 |
Why?
|
Cadherins | 1 | 2022 | 906 | 0.150 |
Why?
|
Mice, Inbred NOD | 3 | 2012 | 1875 | 0.150 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2020 | 627 | 0.140 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2020 | 436 | 0.140 |
Why?
|
Animals | 14 | 2022 | 168561 | 0.140 |
Why?
|
Mice | 10 | 2022 | 81045 | 0.140 |
Why?
|
Epitopes | 1 | 2022 | 2569 | 0.130 |
Why?
|
Lethargy | 1 | 2015 | 39 | 0.130 |
Why?
|
BRCA2 Protein | 1 | 2020 | 790 | 0.130 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2022 | 2107 | 0.130 |
Why?
|
Mammary Glands, Animal | 2 | 2020 | 277 | 0.120 |
Why?
|
Genetic Heterogeneity | 1 | 2017 | 732 | 0.120 |
Why?
|
BRCA1 Protein | 1 | 2020 | 1145 | 0.110 |
Why?
|
Smad7 Protein | 1 | 2012 | 41 | 0.100 |
Why?
|
Tumor Microenvironment | 2 | 2022 | 3564 | 0.100 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2012 | 126 | 0.100 |
Why?
|
Sequence Analysis, RNA | 1 | 2020 | 2011 | 0.100 |
Why?
|
Cell Separation | 1 | 2017 | 1749 | 0.100 |
Why?
|
Lymphangiogenesis | 1 | 2012 | 172 | 0.100 |
Why?
|
Humans | 23 | 2024 | 742088 | 0.090 |
Why?
|
Cell Survival | 1 | 2021 | 5872 | 0.090 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2187 | 0.090 |
Why?
|
Neovascularization, Pathologic | 1 | 2021 | 2633 | 0.090 |
Why?
|
Cell Communication | 1 | 2017 | 1619 | 0.090 |
Why?
|
Reactive Oxygen Species | 1 | 2017 | 2077 | 0.090 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 625 | 0.090 |
Why?
|
Cell Dedifferentiation | 1 | 2010 | 135 | 0.090 |
Why?
|
Smad3 Protein | 1 | 2009 | 180 | 0.080 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2011 | 473 | 0.080 |
Why?
|
Proteomics | 1 | 2022 | 3618 | 0.080 |
Why?
|
Metaplasia | 1 | 2009 | 313 | 0.080 |
Why?
|
Cell Movement | 1 | 2021 | 5212 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3691 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2020 | 5163 | 0.080 |
Why?
|
Down-Regulation | 1 | 2015 | 3001 | 0.080 |
Why?
|
MicroRNAs | 2 | 2015 | 3731 | 0.080 |
Why?
|
Signal Transduction | 6 | 2020 | 23387 | 0.080 |
Why?
|
Up-Regulation | 3 | 2012 | 4211 | 0.080 |
Why?
|
Headache | 1 | 2015 | 1219 | 0.080 |
Why?
|
Leukemia | 1 | 2015 | 1507 | 0.070 |
Why?
|
Blood Platelets | 1 | 2017 | 2506 | 0.070 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2020 | 2906 | 0.070 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2015 | 2948 | 0.060 |
Why?
|
Female | 12 | 2023 | 379592 | 0.060 |
Why?
|
Genomic Instability | 1 | 2008 | 695 | 0.060 |
Why?
|
Phenotype | 1 | 2021 | 16331 | 0.060 |
Why?
|
Cell Differentiation | 2 | 2010 | 11470 | 0.050 |
Why?
|
Apoptosis | 1 | 2018 | 9715 | 0.050 |
Why?
|
Transplantation, Heterologous | 1 | 2009 | 2382 | 0.050 |
Why?
|
Dual Specificity Phosphatase 1 | 1 | 2020 | 44 | 0.050 |
Why?
|
Disease Progression | 2 | 2023 | 13256 | 0.050 |
Why?
|
Transcription, Genetic | 2 | 2012 | 7721 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2023 | 535 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2020 | 8829 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2022 | 11039 | 0.040 |
Why?
|
Promoter Regions, Genetic | 1 | 2010 | 5867 | 0.040 |
Why?
|
Hep G2 Cells | 1 | 2020 | 392 | 0.040 |
Why?
|
Spheroids, Cellular | 1 | 2020 | 351 | 0.040 |
Why?
|
Stereotaxic Techniques | 1 | 2020 | 535 | 0.040 |
Why?
|
K562 Cells | 1 | 2020 | 632 | 0.040 |
Why?
|
Cell Hypoxia | 1 | 2020 | 675 | 0.040 |
Why?
|
Phthalazines | 1 | 2020 | 361 | 0.040 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2020 | 697 | 0.040 |
Why?
|
Mutation | 2 | 2020 | 29717 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2011 | 5851 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 2 | 2023 | 5522 | 0.030 |
Why?
|
DNA Nucleotidylexotransferase | 1 | 2015 | 64 | 0.030 |
Why?
|
Mental Disorders | 1 | 2015 | 6587 | 0.030 |
Why?
|
Prognosis | 3 | 2012 | 29010 | 0.030 |
Why?
|
Piracetam | 1 | 2015 | 87 | 0.030 |
Why?
|
Nootropic Agents | 1 | 2015 | 160 | 0.030 |
Why?
|
Brain | 1 | 2020 | 26343 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2015 | 380 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2020 | 6313 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2020 | 3557 | 0.030 |
Why?
|
Metabolomics | 1 | 2020 | 1467 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2938 | 0.030 |
Why?
|
Gene Expression Profiling | 3 | 2012 | 9410 | 0.020 |
Why?
|
Cell Cycle | 1 | 2020 | 2964 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2020 | 4187 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2020 | 3504 | 0.020 |
Why?
|
Craniotomy | 1 | 2015 | 729 | 0.020 |
Why?
|
Proteome | 1 | 2020 | 1790 | 0.020 |
Why?
|
Piperazines | 1 | 2020 | 2488 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2011 | 553 | 0.020 |
Why?
|
Cyclin A1 | 1 | 2008 | 11 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2015 | 1835 | 0.020 |
Why?
|
Cyclin A | 1 | 2008 | 60 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2020 | 4414 | 0.020 |
Why?
|
Dexamethasone | 1 | 2015 | 1949 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3585 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2012 | 13019 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2008 | 400 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2015 | 1509 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2008 | 677 | 0.020 |
Why?
|
Tumor Burden | 1 | 2012 | 1905 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2012 | 2713 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2020 | 10472 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2012 | 2906 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2020 | 19223 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4751 | 0.010 |
Why?
|
Blotting, Western | 1 | 2011 | 5180 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2012 | 3920 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2023 | 77098 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2012 | 6382 | 0.010 |
Why?
|
RNA Interference | 1 | 2011 | 2890 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 21821 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6534 | 0.010 |
Why?
|
DNA Damage | 1 | 2008 | 2423 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2011 | 11363 | 0.010 |
Why?
|
Fibroblasts | 1 | 2008 | 4143 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2012 | 18006 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20086 | 0.010 |
Why?
|
Male | 2 | 2022 | 349538 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 35342 | 0.000 |
Why?
|
Aged | 1 | 2020 | 162944 | 0.000 |
Why?
|
Middle Aged | 1 | 2020 | 213127 | 0.000 |
Why?
|
Adult | 1 | 2015 | 213712 | 0.000 |
Why?
|